FDA Approves a New HER2-targeted Therapeutic for Breast Cancer
Earlier this week, the U.S. Food and Drug Administration (FDA) approved a new molecularly targeted therapeutic called neratinib (Nerlynx)...
Tag: Breast cancer
Earlier this week, the U.S. Food and Drug Administration (FDA) approved a new molecularly targeted therapeutic called neratinib (Nerlynx)...
Earlier this week, the U.S. Food and Drug Administration approved the molecularly targeted therapeutic ribociclib (Kisqali) for use in...
The fact that there are differences in screening mammography recommendations highlights the need for additional research into the benefits...
Results from the phase III clinical trial BELLE-3, presented at the San Antonio Breast Cancer Symposium on Dec. 8,...
Data presented at the San Antonio Breast Cancer Symposium showed that five additional years of the aromatase inhibitor (AI)...
A study presented Thursday, Dec. 8, at the San Antonio Breast Cancer Symposium found that women who received breast...
Genomic analysis of estrogen receptor (ER)-positive metastatic breast cancer samples that had become resistant to therapies revealed multiple alterations...
SABCS is a comprehensive scientific meeting that provides the latest information on prevention, diagnosis, and treatment of breast cancer...
Sasha Stanton, MD, PhD, is a breast cancer physician-scientist dedicated to developing a DCIS vaccine.
This month is Breast Cancer Awareness Month, a type of cancer against which we have made much progress. However,...